I have a point of order, Mr. Chair.
This is an important conversation that we're having. We need to get through this study, obviously, but I'd like to resume the debate on my opioids motion from last week. I move that we resume that debate on the opioids motion from last week, Mr. Chair.
Colleagues, there was an article over the weekend that really brings home the problem that I want to—